Dengue fever in a multiple sclerosis patient taking Ocrelizumab.

Guerra, Tommaso; Bollo, Luca; Trojano, Maria; Iaffaldano, Pietro

Guerra, Tommaso; Bollo, Luca; Trojano, Maria; Iaffaldano, Pietro.

Afiliación

Guerra T; Department of Basic Medical Sciences, Neurosciences and Sense Organs, University of Bari "Aldo Moro," Bari, Italy.
Bollo L; Department of Basic Medical Sciences, Neurosciences and Sense Organs, University of Bari "Aldo Moro," Bari, Italy.
Trojano M; Department of Basic Medical Sciences, Neurosciences and Sense Organs, University of Bari "Aldo Moro," Bari, Italy.
Iaffaldano P; Department of Basic Medical Sciences, Neurosciences and Sense Organs, University of Bari "Aldo Moro," Bari, Italy.

Mult Scler ; 27(13): 2116-2118, 2021 11.

Article en En | MEDLINE | ID: mdl-34449289

Asunto(s)

Dengue; Esclerosis Múltiple Recurrente-Remitente; Esclerosis Múltiple; Anticuerpos Monoclonales Humanizados/efectos adversos; Dengue/complicaciones; Dengue/tratamiento farmacológico; Humanos; Factores Inmunológicos/efectos adversos; Esclerosis Múltiple/tratamiento farmacológico; Esclerosis Múltiple Recurrente-Remitente/tratamiento farmacológico

Palabras clave

Multiple sclerosis; Ocrelizumab; dengue fever

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Esclerosis Múltiple Recurrente-Remitente / Dengue / Esclerosis Múltiple Límite: Humans Idioma: En Revista: Mult Scler Asunto de la revista: NEUROLOGIA Año: 2021 Tipo del documento: Article País de afiliación: Italia

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google